Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Apr, 2019 | Pages:
125 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)
The global biodefense market size is expected to reach USD 6.50 billion by 2025, growing at a CAGR of 4.5% over the forecast period, according to a new report by Grand View Research, Inc. The market is majorly driven by rising focus of the public agencies on mitigating the risk of Chemical, Biological, Radiological and Nuclear (CBRN) threats and increased funding for biodefense. Biomedical Advanced Research and Development Authority (BARDA), National Interagency Confederation for Biological Research (NICBR), and National Institute of Allergy and Infectious Diseases (NIAID) are major organizations that provide financial support for biodefense research and stockpiling in U.S. Ongoing research for the development of vaccinations and anti-toxins against biological threats, such as Zika virus, is also one of the key drivers contributing to the market growth. For instance, Ohio State University is undertaking a progressive research to develop a vaccine against the Zika virus that has proven beneficial results in the mice models. According to a survey, in Brazil, around 2,952 confirmed cases of Zika-related microcephaly in newborns were reported. Thus, rising risk of biological threats and subsequently rising R&D funding are augmenting the growth of this market. Presence of EUA policy in U.S. is also positively impacting the market growth. The EUA policy empowers FDA Commissioners to allow and authorize the usage of a medical product(s) for commercial use, at the time of a declared emergency in the country posing a threat to public health, that are currently unapproved or an application of an approved medical product for a particular indication is unapproved by the FDA. The government agencies issued the EUA policy for antiviral drugs to fight against diseases, such as Zika virus infection and swine flu. Further key findings from the study suggest: • Anthrax held the largest share in 2018 owing to increased investments by government agencies and collaborations between public and private companies to develop and stockpile anthrax vaccines • Others segment consists of chemical and biological products. It accounted for the second-largest revenue share in 2018 • Small pox is expected to be the fastest-growing product segment of the global biodefense market over the forecast period • North America was the largest regional market owing to favorable government initiatives and funding in the field of biodefense • Europe is expected to witness the maximum growth rate from 2019 to 2025 on account of growing focus of the European countries to enhance the preparedness against CBRN threats • Some of the key companies in the global market include PharmAthene, Inc.; Emergent BioSolutions, Inc.; SIGA Technologies, Inc.; and Xoma Corporation
Table of Contents
Chapter 1 Research Methodology
1.1 Market Segmentation & Scope
1.2 Market Definition
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR's Internal database
1.3.3 Secondary sources & third party perspectives
1.3.4 Primary research:
1.4 Information Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Data Visualization
1.6 Data Validation & Publishing
Chapter 2 Executive Summary
2.1 Biodefense Market Outlook, 2014 - 2025 (USD Million)
2.2 Biodefense Segment Outlook, 2014 - 2025 (USD Million)
2.3 Biodefense Competitive Insights Outlook, 2014 - 2025 (USD Million)
Chapter 3 Biodefense Market Variables, Trends & Scope
3.1 Biodefense Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/ancillary market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Product Pipeline Analysis
3.4 User Perspective Analysis
3.4.1 End-user behaviour analysis
3.4.2 Market influencer analysis
3.5 List of Key End-users
3.6 Technology Overview
3.6.1 Technology timeline
3.7 Regulatory Framework
3.7.1 Standards and compliances
3.8 Biodefense Market Dynamics
3.8.1 Market driver analysis
3.8.2 Market restraint analysis
3.8.3 Industry challenges
3.9 Biodefense Market Analysis Tools
3.9.1 Industry analysis - Porter's
3.9.1.1 Supplier power
3.9.1.2 Buyer power
3.9.1.3 Substitution threat
3.9.1.4 Threats from new entrant
3.9.1.5 Competitive rivalry
3.9.2 PESTEL analysis
3.9.2.1 Political landscape
3.9.2.2 Enviornmental landscape
3.9.2.3 Social landscape
3.9.2.4 Technology landscape
3.9.2.5 Economic landscape
3.9.2.6 Legal landscape
3.9.3 Major deals & strategic alliances analysis
3.9.3.1 Joint ventures
3.9.3.2 Mergers & acquisitions
3.9.3.3 Strategic partnerships
3.9.4 Market entry strategies
Chapter 4 Biodefense Market- Competitive Analysis
4.1 Recent developments & impact analysis, by key market participants
4.2 Company/Competition Categorization
4.3 Vendor Landscape
4.3.1 Key Customers
4.3.2. Funding outlook
4.4 Public Companies
4.4.1 Company market position analysis
4.4.2 Company ranking, by region
4.5 Private Companies
4.5.1 List of key emerging companies /technology disruptors/innovators
4.5.2 Regional network map
4.5.3 Company market position analysis
Chapter 5 Biodefense Market: Product Estimates & Trend Analysis
5.1 Definition & Scope
5.2 Product Market Share Analysis, 2018 & 2025
5.3 Segment Dashboard
5.4 Global Biodefense Market Revenue Estimates and Forecasts, by Product, 2014 - 2025 (USD Million)
5.4.1 Anthrax
5.4.1.1 Anthrax market revenue estimates and forecasts, 2014 - 2025 (USD Million)
5.4.2 Small pox
5.4.2.1 Small Pox Market revenue estimates and forecasts, 2014 - 2025 (USD Million)
5.4.3 Botulism
5.4.3.1 Botulism market revenue estimates and forecasts, 2014 - 2025 (USD Million)
5.4.4 Radiation/Nuclear Defense
5.4.4.1 Radiation/nuclear defense market revenue estimates and forecasts, 2014 - 2025 (USD Million)
5.4.5 Others
5.4.5.1 Others market revenue estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 6 Biodefense Market: Regional Estimates & Trend Analysis, By Product
6.1 Regional Biodefense Market Snapshot, 2018 & 2025 (market size, CAGR, top verticals, top trends)
6.2 Leading Players, by Region, 2018
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East & Africa
6.3 North America
6.3.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.3.2 U.S.
6.3.2.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.3.3 Canada
6.3.3.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.4 Europe
6.4.1. Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.4.2 U.K.
6.4.2.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.4.3 Germany
6.4.3.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.4.4 France
6.4.4.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.4.5 Spain
6.4.5.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.4.6 Italy
6.4.6.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.4.7 Russia
6.4.7.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.5 Asia Pacific
6.5.1. Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.5.2 Japan
6.5.2.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.5.3 China
6.5.3.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.5.4 India
6.5.4.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.5.5 Australia
6.5.5.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.5.6 Singapore
6.5.6.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.5.7 South Korea
6.5.7.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.6 Latin America
6.6.1. Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.6.2 Brazil
6.6.2.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.6.3 Mexico
6.6.3.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.6.4 Argentina
6.6.4.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.7 MEA
6.7.1. Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.7.2 South Africa
6.7.2.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.7.3 Saudi Arabia
6.7.3.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.7.4 UAE
6.7.4.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.8 SWOT Analysis, by Factor
6.8.1 North America
6.8.2 Europe
6.8.3 Asia Pacific
6.8.4 Latin America
6.8.5 Middle East & Africa
Chapter 7 Competitive Landscape
7.1 Company Profiles
7.1.1 Xoma Corporation
7.1.1.1 Company overview
7.1.1.2 Financial performance
7.1.1.3 Product benchmarking
7.1.1.4 Strategic initiatives
7.1.2 Altimune, Inc. (PharmAthene, Inc.)
7.1.2.1 Company overview
7.1.2.2 Financial performance
7.1.2.3 Product benchmarking
7.1.2.4 Strategic initiatives
7.1.3 Emergent Biosolutions Inc.
7.1.3.1 Company Overview
7.1.3.2 Financial Performance
7.1.3.3 Product Benchmarking
7.1.3.4 Strategic Initiatives
7.1.4 Dynavax Technologies Corporation
7.1.4.1 Company overview
7.1.4.2 Financial performance
7.1.4.3 Product benchmarking
7.1.4.4 Strategic initiatives
7.1.5 SIGA Technologies, Inc.
7.1.5.1 Company Overview
7.1.5.2 Financial Performance
7.1.5.3 Product Benchmarking
7.1.5.4 Strategic Initiatives
7.1.6 Elusys Therapeutics, Inc.
7.1.6.1 Company Overview
7.1.6.2 Financial Performance
7.1.6.3 Product Benchmarking
7.1.6.4 Strategic Initiatives
7.1.7 B.Ichor Medical Systems
7.1.7.1 Company overview
7.1.7.2 Financial performance
7.1.7.3 Product benchmarking
7.1.7.4 Strategic initiatives
7.1.8 Dynport Vaccine Company LLC
7.1.8.1 Company overview
7.1.8.2 Financial performance
7.1.8.3 Product benchmarking
7.1.8.4 Strategic initiatives
7.1.9 Cleveland Biolabs
7.1.9.1 Company overview
7.1.9.2 Financial performance
7.1.9.3 Product benchmarking
7.1.9.4 Strategic initiatives
7.1.10 Bavarian Nordic
7.1.10.1 Company overview
7.1.10.2 Financial performance
7.1.10.3 Product benchmarking
7.1.10.4 Strategic initiatives
7.1.11 Achaogen, Inc
7.1.11.1 Company overview
7.1.11.2 Financial performance
7.1.11.3 Product benchmarking
7.1.11.4 Strategic initiatives
7.1.12 Nanotherapeutics, Inc.
7.1.12.1 Company overview
7.1.12.2 Financial performance
7.1.12.3 Product benchmarking
7.1.12.4 Strategic initiatives
7.1.13 Alnylam Pharmaceuticals, Inc.
7.1.13.1 Company overview
7.1.13.2 Financial performance
7.1.13.3 Product benchmarking
7.1.13.4 Strategic initiatives
7.2 List of other companies
List of Tables Table 1. Biodefense market: Pipeline Analysis Table 2. List of key end - users Table 3. Company wise list of approved EUA products for Zika Virus Table 4. Company wise list of approved EUA products for Enterovirus D68 Table 5. Company wise list of approved EUA products for Ebola Virus Table 6. Company wise list of approved EUA products for Coronavirus Table 7. Company wise list of approved EUA products for H7N9 Influenza Table 8. List of organizations contributing for ebola virus outbreak, 2016 Table 9. List of key emerging companies /technology disruptors/innovators Table 10. Funding outlook Table 11. List of key players by region Table 12. North America biodefense market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million) Table 13. U.S. biodefense market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million) Table 14. Canada biodefense market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million) Table 15. Europe biodefense market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million) Table 16. Biodefense program licensed manufacturing sites in the U.K. Table 17. U.K. biodefense market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million) Table 18. Germany biodefense market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million) Table 19. France biodefense market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million) Table 20. Spain biodefense market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million) Table 21. Italy biodefense market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million) Table 22. Russia biodefense market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million) Table 23. Asia Pacific biodefense market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million) Table 24. Japan biodefense market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million) Table 25. China biodefense market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million) Table 26. India biodefense market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million) Table 27. South Korea biodefense market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million) Table 28. Singapore biodefense market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million) Table 29. Australia biodefense market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million) Table 30. Latin America biodefense market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million) Table 31. Brazil biodefense market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million) Table 32. Mexico biodefense market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million) Table 33. Argentina biodefense market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million) Table 34. MEA biodefense market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million) Table 35. South Africa biodefense market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million) Table 36. Saudi Arabia biodefense market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million) Table 37. UAE biodefense market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million) Table 38. List of other key players Table 39. Market segmentation Table 40. Market research process Table 41. Data triangulation techniques Table 42. Primary research pattern Table 43. Market research approaches Table 44. Value chain based sizing & forecasting Table 45. QFD modelling for market share assessment Table 46. Market formulation & validation Table 47. Market segmentation Table 48. Market summary, 2018 (USD Million) Table 49. Guidewires market trends Table 50. Penetration & growth prospect mapping Table 51. Technology timeline Table 52. Market driver relevance analysis (Current & future impact) Table 53. U.S. government civilian biodefense funding, by agencies, (USD Million) Table 54. Market restraint relevance analysis (Current & future impact) Table 55. Participant categorization Table 56. Company market position analysis, 2018 (Public companies) Table 57. Company market position analysis, 2018 (Private companies) Table 58. Regional network map Table 59. Biodefense market: Market share analysis, by product Table 60. Biodefense market: Segment Dashboard for product segment, USD Million Table 61. Biodefense against anthrax market revenue estimates and forecast, 2014 - 2025 (USD Million) Table 62. Biodefense against small pox market revenue estimates and forecast, 2014 - 2025 (USD Million) Table 63. Biodefense against botulism market revenue estimates and forecast, 2014 - 2025 (USD Million) Table 64. Radiation/nuclear biodefense market revenue estimates and forecast, 2014 - 2025 (USD Million) Table 65. Others biodefense market revenue estimates and forecast, 2014 - 2025 (USD Million) Table 66. Biodefense Market: Regional snapshot Table 67. Regional market share analysis, 2018 & 2025 (USD Million) Table 68. North America biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Table 69. U.S. biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Table 70. Canada biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Table 71. Europe biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Table 72. U.K. biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Table 73. Germany biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Table 74. Spain biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Table 75. France biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Table 76. Italy biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Table 77. Russia biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Table 78. Asia Pacific biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Table 79. Japan biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Table 80. China biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Table 81. India biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Table 82. South Korea biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Table 83. Singapore biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Table 84. Australia biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Table 85. Latin America biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Table 86. Brazil biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Table 87. Mexico biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Table 88. Argentina biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Table 89. MEA biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Table 90. Saudi Arabia biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Table 91. South Africa biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Table 92. UAE biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million)
List of Figures Fig. 1 Market segmentation Fig. 2 Market research process Fig. 3 Data triangulation techniques Fig. 4 Primary research pattern Fig. 5 Market research approaches Fig. 6 Value chain based sizing & forecasting Fig. 7 QFD modelling for market share assessment Fig. 8 Market formulation & validation Fig. 9 Market segmentation Fig. 10 Market summary, 2018 (USD Million) Fig. 11 Guidewires market trends Fig. 12 Penetration & growth prospect mapping Fig. 13 Technology timeline Fig. 14 Market driver relevance analysis (Current & future impact) Fig. 15 U.S. government civilian biodefense funding, by agencies, (USD Million) Fig. 16 Market restraint relevance analysis (Current & future impact) Fig. 17 Participant categorization Fig. 18 Company market position analysis, 2018 (Public companies) Fig. 19 Company market position analysis, 2018 (Private companies) Fig. 20 Regional network map Fig. 21 Biodefense market: Market share analysis, by product Fig. 22 Biodefense market: Segment Dashboard for product segment, USD Million Fig. 23 Biodefense against anthrax market revenue estimates and forecast, 2014 - 2025 (USD Million) Fig. 24 Biodefense against small pox market revenue estimates and forecast, 2014 - 2025 (USD Million) Fig. 25 Biodefense against botulism market revenue estimates and forecast, 2014 - 2025 (USD Million) Fig. 26 Radiation/nuclear biodefense market revenue estimates and forecast, 2014 - 2025 (USD Million) Fig. 27 Others biodefense market revenue estimates and forecast, 2014 - 2025 (USD Million) Fig. 28 Biodefense Market: Regional snapshot Fig. 29 Regional market share analysis, 2018 & 2025 (USD Million) Fig. 30 North America biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Fig. 31 U.S. biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Fig. 32 Canada biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Fig. 33 Europe biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Fig. 34 UK biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Fig. 35 Germany biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Fig. 36 Spain biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Fig. 37 France biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Fig. 38 Italy biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Fig. 39 Russia biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Fig. 40 Asia Pacific biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Fig. 41 Japan biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Fig. 42 China biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Fig. 43 India biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Fig. 44 South Korea biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Fig. 45 Singapore biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Fig. 46 Australia biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Fig. 47 Latin America biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Fig. 48 Brazil biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Fig. 49 Mexico biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Fig. 50 Argentina biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Fig. 51 MEA biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Fig. 52 Saudi Arabia biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Fig. 53 South Africa biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million) Fig. 54 UAE biodefense market revenue estimates and forecasts, 2014 - 2025 (USD Million)
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
